Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

Suspected Familial Insulinomatosis Case Report Highlights Diagnostic Limits

A Lancet Oncology case report examines suspected familial insulinomatosis and the diagnostic and treatment barriers faced in a low-resource setting.

A review links PMOS/PCOS to memory changes and possible dementia risk, with insulin resistance and obesity likely driving…

Lisa B. Nachtigall receives the Endocrine Society’s 2026 Vigersky Award for pituitary care, mentorship, and access-focused endocrine practice.

The Endocrine Society named 13 endocrinology leaders for its 2027 Laureate Awards, recognizing research, care, education, and mentorship.

At ENDO 2026, Kavaljit Chhabra outlined how leadership mistakes, not just failed experiments, can slow endocrine research and…

STEP 12 evaluated weekly semaglutide 2.4 mg in adults in China and Taiwan with overweight or obesity, using…

An endocrinologist argues health plans should expand GLP-1 coverage, citing obesity, cardiometabolic benefits and long-term cost savings.

Roche licensed a Rona Therapeutics ALK7 RNAi drug for obesity, betting on extrahepatic gene silencing to stand apart…

MHRA warns that recalled Nova Biomedical ketone strips may disrupt blood ketone testing and delay DKA recognition, monitoring,…

Efzimfotase alfa showed numerical gains in the HICKORY phase 3 trial for hypophosphatasia, but the 6MWT endpoint did…

Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

In Brief The 5-minute rounds